Dubai-based Metabolic has rebranded from its former moniker of GluCare.Health, stepping beyond its roots as a diabetes-focused clinic to position itself as a broader metabolic health platform.

Launched in 2020 by Ali Hashemi, Dr. Ihsan Almarzooqi and Zeina Abdalla, the company says the name change reflects how its clinical model has widened over five years in the UAE. Instead of centering solely on glucose control, it now targets metabolic syndrome as a web of linked risks — from obesity and cardiovascular disease to fatty liver disease, PCOS and chronic kidney disease.

The core product is what the company calls “Metabolic OS,” a hybrid care operating system that connects diagnostics, continuous remote monitoring and AI-driven decision support inside a clinician-led model. The pitch centers on delivering fewer disconnected tests, and more coordinated oversight between visits.

“Over five years we’ve built what we wish the healthcare system had from day one: an operating system for metabolic risk,” said Ali Hashemi, CEO and co-founder. “Not a collection of apps, devices, and disconnected tests, but an integrated model where data becomes signal, signal becomes action, and action translates into outcomes. AI is most powerful when it supports great clinicians and helps patients stay engaged between visits. That’s the DNA of Metabolic OS”.

The shift comes as the Middle Eastern health sector grapples with some of the highest diabetes and obesity rates globally. In the UAE, many people with type 2 diabetes remain uncontrolled, while the same underlying drivers spill into heart disease and endocrine disorders.

Also Read: Private Jet Operator AirX Wins Saudi Aviation Clearance

“[Those] metabolic drivers are fueling obesity, cardiovascular disease, fatty liver disease, and hormonal disorders,” said Dr. Ihsan Almarzooqi, managing director and co-founder. “The clinical need is clear: earlier detection, better risk stratification, and longitudinal support. The technology now exists to do this well, but only if it’s integrated into a coordinated care model. That’s what we’ve built”.

Metabolic’s services now span endocrinology, cardiology, obesity management, sleep-related metabolic disorders and hormone care for men and women. Preventive health and executive risk assessments are part of the mix.

The company cites 2025 real-world publications showing HbA1c reductions of up to 2.3 percentage points, around 10% weight loss within three months, and improvements in triglycerides and blood pressure. It also reported stronger muscle preservation among patients using GLP-1 therapies.

GluCare.Health will remain as the group’s research and evidence arm.